Diabetes drug tested as potential breakthrough for opioid addiction
Disease control
Recruiting now
This study is testing whether adding tirzepatide, a medication currently used for diabetes and weight loss, to standard buprenorphine treatment helps people with opioid addiction. Researchers will enroll 310 adults who recently started buprenorphine treatment and randomly assign …
Phase: PHASE2 • Sponsor: T. John Winhusen, PhD • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC